Copyright
©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 15, 2004; 10(8): 1146-1151
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1146
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1146
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma
Ming Shi, Bing Zhang, Zi-Rong Tang, Zhou-Yun Lei, Hui-Fen Wang, Yong-Yi Feng, Zhen-Ping Fan, Dong-Ping Xu, Fu-Sheng Wang, Division of Biological Engineering, Institute of Infectious Diseases, 302 Hospital of PLA, Beijing 100039, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Fu-Sheng Wang, Research Center of Biotherapy, Beijing Institute of Infectious Diseases, 302 Hospital of PLA, Beijing 100039, China. fswang@public.bat.net.cn
Telephone: +86-10-66933332 Fax: +86-10-63831870
Received: August 23, 2003
Revised: September 18, 2003
Accepted: October 22, 2003
Published online: April 15, 2004
Revised: September 18, 2003
Accepted: October 22, 2003
Published online: April 15, 2004
Core Tip